Конъюктивит COVID-19 с осложненным течением. Случай из практикиBabushkin, Alexander E.,
Matyukhina, Ekaterina N.,
Saitova, Gulnaz R.,
Israfilova, Gulnara Z.,
Бабушкин, А.Э.,
Матюхина, Е.Н.,
Саитова, Г.Р.,
Исрафилова, Г.З. (2023) solutions of glucocorticosteroid, a cytostatic and an antiseptic combined with tear replacement
therapy Shnayder, N.A.,
Grechkina, V.V.,
Khasanova, A.K.,
Bochanova, E.N.,
Dontceva, E.A.,
Petrova, M.M.,
Asadullin, A.R.,
Shipulin, G.A.,
Altynbekov, K.S.,
Al-Zamil, M.,
Nasyrova, R.F. (2023) -modifying
therapy for multiple tumors, neurodegenerative diseases (Huntington’s disease, Parkinson’s disease
Mead, Gillian E,
Sposato, Luciano A,
Sampaio Silva, Gisele,
Yperzeele, Laetitia,
Wu, Simiao,
Kutlubaev, Mansur,
Cheyne, Joshua,
Wahab, Kolawole,
Urrutia, Victor C,
Sharma, Vijay K,
Sylaja, PN,
Hill, Kelvin,
Steiner, Thorsten,
David S, Liebeskind,
Rabinstein, lejandro A (2023) for reperfusion
therapies for acute ischemic stroke. For secondary prevention, strong recommendations included